Insider Stock Trading History of Gergel Ivan P.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Gergel Ivan P. since year 2005. The trader's CIK number is 1328288. At the time of this reporting, Gergel Ivan P. is the SVP & Chief Medical Officer of Nektar Therapeutics . (stock ticker symbol NKTR). See this page for all insider trading activities at Nektar Therapeutics .

Note that in the past Gergel Ivan P. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Gergel Ivan P. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-02 NKTR Nektar Therapeutics Option Ex 56,704 11.04 626,012
2017-10-02 NKTR Nektar Therapeutics Sale 56,704 24.21 1,372,803
2017-09-29 NKTR Nektar Therapeutics Option Ex 43,296 11.04 477,987
2017-09-29 NKTR Nektar Therapeutics Sale 43,296 24.04 1,040,835
2017-08-16 NKTR Nektar Therapeutics Sale 1,997 19.32 38,582
2017-07-18 NKTR Nektar Therapeutics Option Ex 54,920 11.04 606,316
2017-07-18 NKTR Nektar Therapeutics Sale 54,920 21.10 1,158,812
2017-07-12 NKTR Nektar Therapeutics Sale 36,691 21.09 773,813
2017-07-11 NKTR Nektar Therapeutics Sale 8,389 21.04 176,504
2017-07-12 NKTR Nektar Therapeutics Option Ex 36,691 11.04 405,068
2017-07-11 NKTR Nektar Therapeutics Option Ex 8,389 11.04 92,614
2017-05-16 NKTR Nektar Therapeutics Sale 1,450 19.55 28,347
2017-02-16 NKTR Nektar Therapeutics Sale 1,457 13.14 19,144
2016-11-16 NKTR Nektar Therapeutics Sale 848 13.96 11,838
2016-08-16 NKTR Nektar Therapeutics Sale 1,685 17.56 29,588
2016-05-16 NKTR Nektar Therapeutics Option Ex 1,250 .00 0
2016-05-17 NKTR Nektar Therapeutics Sale 432 13.58 5,866
2016-02-16 NKTR Nektar Therapeutics Option Ex 1,250 .00 0
2016-02-17 NKTR Nektar Therapeutics Sale 556 11.92 6,627
2014-03-10 ENDP Endo International Plc Sale 75,637 72.47 5,481,413
2014-03-10 ENDP Endo International Plc Option Ex 75,637 30.02 2,270,774
2013-04-24 ENDP Endo Pharmaceuticals Holdings Inc Option Ex 105,190 21.85 2,298,717
2013-04-24 ENDP Endo Pharmaceuticals Holdings Inc Sale 138,225 36.46 5,039,268
2012-12-31 ENDP Endo Pharmaceuticals Holdings Inc Option Ex 33,271 .00 0
2011-05-03 ENDP Endo Pharmaceuticals Holdings Inc Option Ex 12,500 25.02 312,750
2011-05-03 ENDP Endo Pharmaceuticals Holdings Inc Sale 12,500 39.39 492,375
2011-02-28 ENDP Endo Pharmaceuticals Holdings Inc Option Ex 30,603 19.93 609,917
2011-03-02 ENDP Endo Pharmaceuticals Holdings Inc Sale 30,603 35.77 1,094,669
2011-02-23 ENDP Endo Pharmaceuticals Holdings Inc Option Ex 26,632 .00 0
2011-02-24 ENDP Endo Pharmaceuticals Holdings Inc Option Ex 15,742 20.61 324,442
2011-02-24 ENDP Endo Pharmaceuticals Holdings Inc Sale 15,742 33.59 528,773
2010-12-03 ENDP Endo Pharmaceuticals Holdings Inc Option Ex 55,603 22.48 1,249,677
2010-12-03 ENDP Endo Pharmaceuticals Holdings Inc Sale 55,603 36.53 2,031,177
2007-02-14 FRX Forest Laboratories Inc Option Ex 32,250 38.87 1,253,557
2007-02-14 FRX Forest Laboratories Inc Sale 32,250 53.45 1,723,859

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gergel Ivan P. (SVP & Chief Medical Officer of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.